Search research articles
Contact Us
Filters
Showing results (251-260 of 313) with videos related to
Page
of 32
Sort By:
Drug and Chemical Toxicology
|
January 20, 1998
Chemical and toxicological evaluation of pyrotechnically disseminated terephthalic acid smoke
W T Muse, J S Anthony, J D Bergmann, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
July 1, 1995
Regression of atherosclerosis in female monkeys
J K Williams, M S Anthony, E K Honoré, et al.
Journal of Alzheimer'S Disease : JAD
|
November 28, 2024
Natural history and clinical outcomes in patients with Alzheimer's disease-related psychosis by antipsychotic treatment status in the United States
Sapna Rao, Joan Forns, Heather E Danysh, et al.
Pharmacoepidemiology and Drug Safety
|
March 17, 2025
A Comparative Real-World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy
J Bradley Layton, Colin Anderson-Smits, Zhongwen Huang, et al.
Clinical Radiology
|
January 15, 2013
Prospective study evaluating technical and clinical outcomes from the use of low profile angioplasty (LOPA) systems
C R Tapping, M W Little, J H Briggs, et al.
BMC Geriatrics
|
October 6, 2022
Clinical outcomes and treatment patterns of older adults with dementia-related psychosis by dementia type in the United States
Joan Forns, Heather E Danysh, Lisa J McQuay, et al.
Journal of Clinical Epidemiology
|
July 23, 2003
Prospective association between hormone replacement therapy, heart rate, and heart rate variability. The Atherosclerosis risk in communities study
Mercedes R Carnethon, Mary S Anthony, Wayne E Cascio, et al.
The Journal of Biological Chemistry
|
September 10, 2010
The N domain of human angiotensin-I-converting enzyme: the role of N-glycosylation and the crystal structure in complex with an N domain-specific phosphinic inhibitor, RXP407
Colin S Anthony, Hazel R Corradi, Sylva L U Schwager, et al.
Drug Safety
|
April 9, 2025
Evaluation of Mortality in Users of Pimavanserin Compared with Other Atypical Antipsychotics in Patients with Parkinson's Disease Psychosis: An Update
Sapna Rao, Lisa J McQuay, Joan Forns, et al.
Annals of Epidemiology
|
August 23, 2003
A prospective evaluation of the risk of QT prolongation with hormone replacement therapy: the atherosclerosis risk in communities study
Mercedes R Carnethon, Mary S Anthony, Wayne E Cascio, et al.
Page
of 32
Search research articles
Search
Showing results (251-260 of 313) with videos related to
Sort By:
Page
of 32
Drug and Chemical Toxicology
|
January 20, 1998
Chemical and toxicological evaluation of pyrotechnically disseminated terephthalic acid smoke
W T Muse, J S Anthony, J D Bergmann, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
July 1, 1995
Regression of atherosclerosis in female monkeys
J K Williams, M S Anthony, E K Honoré, et al.
Journal of Alzheimer'S Disease : JAD
|
November 28, 2024
Natural history and clinical outcomes in patients with Alzheimer's disease-related psychosis by antipsychotic treatment status in the United States
Sapna Rao, Joan Forns, Heather E Danysh, et al.
Pharmacoepidemiology and Drug Safety
|
March 17, 2025
A Comparative Real-World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy
J Bradley Layton, Colin Anderson-Smits, Zhongwen Huang, et al.
Clinical Radiology
|
January 15, 2013
Prospective study evaluating technical and clinical outcomes from the use of low profile angioplasty (LOPA) systems
C R Tapping, M W Little, J H Briggs, et al.
BMC Geriatrics
|
October 6, 2022
Clinical outcomes and treatment patterns of older adults with dementia-related psychosis by dementia type in the United States
Joan Forns, Heather E Danysh, Lisa J McQuay, et al.
Journal of Clinical Epidemiology
|
July 23, 2003
Prospective association between hormone replacement therapy, heart rate, and heart rate variability. The Atherosclerosis risk in communities study
Mercedes R Carnethon, Mary S Anthony, Wayne E Cascio, et al.
The Journal of Biological Chemistry
|
September 10, 2010
The N domain of human angiotensin-I-converting enzyme: the role of N-glycosylation and the crystal structure in complex with an N domain-specific phosphinic inhibitor, RXP407
Colin S Anthony, Hazel R Corradi, Sylva L U Schwager, et al.
Drug Safety
|
April 9, 2025
Evaluation of Mortality in Users of Pimavanserin Compared with Other Atypical Antipsychotics in Patients with Parkinson's Disease Psychosis: An Update
Sapna Rao, Lisa J McQuay, Joan Forns, et al.
Annals of Epidemiology
|
August 23, 2003
A prospective evaluation of the risk of QT prolongation with hormone replacement therapy: the atherosclerosis risk in communities study
Mercedes R Carnethon, Mary S Anthony, Wayne E Cascio, et al.
Page
of 32